Sofinnova Partners SAS, 10% Owner at CinCor Pharma, Inc. (CINC), bought 133,333 shares at $30.00 ($4.0M) on 2022-08-15, disclosed to the SEC on 2022-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| HOOK | SELL | 2021-03-29 | $749K | — | Filing → |
| HOOK | SELL | 2021-03-26 | $722K | — | Filing → |
| HOOK | SELL | 2021-03-25 | $556K | — | Filing → |